Human immunodeficiency virus (HIV) attacks cells that help the body fight infection, making a person more vulnerable to other infections and diseases. It is spread through contact with the bodily fluids of an HIV-positive person, such as through sex or sharing injection drug equipment. If left untreated, HIV can lead to acquired immunodeficiency syndrome (AIDS), the late stage of HIV infection that occurs when the body’s immune system is badly damaged because of the virus. There is no effective cure for HIV, but with proper medical care, it can be controlled.‚Äč

State of the HIV/AIDS Epidemic in 2019

The state of the global HIV pandemic as of 2019.

Microbial Minutes: How a Second Person Was Cured of HIV

March 12, 2019

HIV/AIDS on ASM Podcasts

July 14, 2020


Virology Nobel Prizes, awards for research on tumor viruses, bacteriophages, virus structure, reverse transcriptase, hepatitis B virus, HIV-1 and human papillomaviruses.

Feb. 21, 2019

Dan Barouch lays out the unique challenges of HIV vaccine development and discusses the ongoing clinical trial with a vaccine developed in his lab.

Progress Toward 90-90-90 UNAIDS Goals

In 2016, the United Nations General Assembly committed to ending the HIV/AIDS epidemic by 2030 using benchmarks meant to galvanize action in closing gaps in HIV testing, the number of patients receiving antiretroviral therapy (ART) and the number of patients maintaining viral suppression. This plan, put forth by the Joint United Nations Programme on HIV/AIDS (UNAIDS), set ambitious interim goals to be reached by 2020: 90% of HIV infected individuals should know their HIV+ status, 90% of those who know their status should be receiving ART treatment and 90% of those in treatment should have low enough viral loads to be considered virally suppressed. Where are we in relationship to these "90-90-90" goals?

Global Progress as of 2019 and U.S. Progress as of 2016, Respectively

Globally, the number of people who are living with HIV, who know their HIV status, who are in treatment and who are virally suppressed, as of 2019, compared to the UNAIDS 2020 90/90/90 goals.
Globally, the number of people who are living with HIV, who know their HIV status, who are in treatment and who are virally suppressed, as of 2019. Blue dotted lines indicate the number of people who would need to be in each stage of the care continuum to meet the UNAIDS 2020 90-90-90 goals. For percentages in white, the denominator is the number of people at the previous stage of care; for example, 82% of people who were aware of their status were receiving ART.
 
In the U.S., the number of people who are living with HIV, who know their HIV status, who are in treatment and who are virally suppressed, as of 2016.
In the U.S., the number of people who are living with HIV, who know their HIV status, who are in treatment and who are virally suppressed, as of 2016. Blue dotted lines indicate the number of people who would need to be in each stage of the care continuum to meet the UNAIDS 2020 90-90-90 goals. For percentages in white, the denominator is the number of people at the previous stage of care; for example, 73% of people who were aware of their status were receiving ART.

Other HIV/AIDS Resources

Most Recent ASM Stories